share_log

诺泰生物(688076.SH):通过药品GMP符合性检查

Nuo Tai Biotech (688076.SH): Passed the pharmaceutical GMP compliance inspection.

Gelonghui Finance ·  Aug 16 04:07

On August 16th, Gelunhui reported that Notai Biology (688076.SH) recently received the "Certificate of Export of Active Pharmaceutical Ingredient to the European Union" and the "Notice of Conformity of GMP Inspection of Drugs" issued by Jiangsu Provincial Drug Administration, and the production lines of raw materials (liraglutide, only for processing documents for export to the European Union) in workshop 106 of the Lianyungang factory, production lines of raw materials (exenatide) in workshop 106, and production lines of raw materials (acetic acid sucrose) in workshop 101, have been inspected on site by the Jiangsu Provincial Drug Administration, and met the requirements of the "Drug Production Quality Management Standard".

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment